featured
Adverse Event Comparison Between GLP-1 Receptor Agonists and Other Antiobesity Medications Following Bariatric Surgery
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adverse event comparison between glucagon-like peptide-1 receptor agonists and other antiobesity medications following bariatric surgery
Diabetes Obes Metab 2024 Jun 27;[EPub Ahead of Print], JM Samuels, KD Niswender, CL Roumie, MD Spann, CR Flynn, F Ye, J Blankush, R Irlmeier, LM Funk, MB PatelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.